Covered recipient · General Payments record
NISHAT KULKARNI
Allopathic & Osteopathic Physicians Psychiatry & Neurology Addiction Psychiatry
General Payments · PY2023
$616.35
- Reported across 9 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2023 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $616.35 | 9 |
By paying entity
PY2023 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Alkermes, Inc. | $345.26 | 6 |
| Teva Pharmaceuticals USA, Inc. | $249.99 | 2 |
| BioXcel Therapeutics, Inc. | $21.10 | 1 |
By program year
All program years on this page · sorted by year
| Program year | Amount | Records |
|---|---|---|
| PY2023 | $616.35 | 9 |
Payment records · PY2023 (9)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| Alkermes, Inc. | $27.33 | 01/12/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1022855011 | CMS |
| Alkermes, Inc. | $27.80 | 03/06/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1022855013 | CMS |
| Alkermes, Inc. | $120.00 | 03/10/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1022855015 | CMS |
| Alkermes, Inc. | $26.92 | 03/16/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1022855017 | CMS |
| Alkermes, Inc. | $23.21 | 03/30/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1022855019 | CMS |
| Alkermes, Inc. | $120.00 | 05/16/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1022855021 | CMS |
| BioXcel Therapeutics, Inc. | $21.10 | 05/08/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1057514729 | CMS |
| Teva Pharmaceuticals USA, Inc. | $125.00 | 02/24/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1056711557 | CMS |
| Teva Pharmaceuticals USA, Inc. | $124.99 | 05/04/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1056711579 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2023
- Source files
- Dataset page · Bulk file · PY2023
- Generated from
- OP_DTL_GNRL_PGYR2023_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.